A Reverse Genetics Study of Resistance to Neuraminidase Inhibitors in An Influenza A/H1N1 Virus
- 1 May 2004
- journal article
- research article
- Published by SAGE Publications in Antiviral Therapy
- Vol. 9 (4) , 577-581
- https://doi.org/10.1177/135965350400900404
Abstract
A system of reverse genetics was used to generate influenza A/H1N1 viruses harbouring neuraminidase (NA) mutations previously associated with resistance to NA inhibitors in various viral subtypes. The His274Tyr and Glu119Gln mutants were rescued whereas the Arg292Lys and Glu119→Gly, Val, Ala or Asp mutants could not be generated. In NA inhibition assays, the His274Tyr mutant was resistant to oseltamivir (430-fold over wild-type) and BCX-1812 (50-fold) but was sensitive to zanamivir. A similar trend was seen when the mutant was evaluated by plaque reduction assay (PRA). The Glu119Gln mutant expressed a low level of resistance to oseltamivir (ninefold) and zanamivir (fourfold) in NA inhibition assay but was only marginally resistant to oseltamivir (fourfold) in PRA. The replication capacity of both mutants, in particular that of the His274Tyr virus, was impaired when compared with the wild-type virus in vitro.Keywords
This publication has 28 references indexed in Scilit:
- Prolonged Shedding of Multidrug-Resistant Influenza A Virus in an Immunocompromised PatientNew England Journal of Medicine, 2003
- Evaluation of Neuraminidase Enzyme Assays Using Different Substrates To Measure Susceptibility of Influenza Virus Clinical Isolates to Neuraminidase Inhibitors: Report of the Neuraminidase Inhibitor Susceptibility NetworkJournal of Clinical Microbiology, 2003
- In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675Journal of Virology, 2002
- In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus ReplicationAntimicrobial Agents and Chemotherapy, 2002
- Neuraminidase inhibitors for the treatment and prevention of influenzaExpert Opinion on Pharmacotherapy, 2002
- Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against Clinical Isolates of Influenza Virus and Neuraminidase Inhibitor-Resistant VariantsAntimicrobial Agents and Chemotherapy, 2001
- Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with OseltamivirThe Journal of Infectious Diseases, 2001
- Rational design of potent sialidase-based inhibitors of influenza virus replicationNature, 1993
- Plaque inhibition assay for drug susceptibility testing of influenza virusesAntimicrobial Agents and Chemotherapy, 1980
- Characterization of temperature sensitive influenza virus mutants defective in neuraminidaseVirology, 1974